Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease ...

The analysis by Ontada tracked testing rates withing the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 years.

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

Roughly 85,000 people in the U.S. will be diagnosed with this common cancer this year alone. Newsom Wants to End Free Health ...

Blue Light Cystoscopy with Cysview utilizes a special scope and dye to detect and treat non muscle invasive bladder cancer.